Drug Monitoring, Panel 6 with Confirmation, Urine
Also known as: Prescription Drug Monitoring, Pain Management
Use
This test panel is intended for comprehensive drug monitoring via urine. It screens for a broad range of drug classes and metabolites—including amphetamines, benzodiazepines, cocaine (metabolites), opiates, barbiturates, and alcohol metabolites like ethyl glucuronide and ethyl sulfate. Creatinine, pH, specific gravity, oxidant, and specimen validity parameters (e.g., abnormal specimen validity test) are also included to assess specimen integrity. Confirmation testing is performed for any initial positive screening result to provide definitive drug exposure status.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Other
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided
